High‐dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre
- 1 July 2004
- journal article
- clinical trial
- Published by Wiley in European Journal of Neurology
- Vol. 11 (7), 475-477
- https://doi.org/10.1111/j.1468-1331.2004.00813.x
Abstract
The aim of this study was to investigate the efficacy of riboflavin for the prevention of migraine. An open label study was performed in a specialized outpatient clinic. Patients received 400 mg riboflavin capsules per day. Headache frequency, duration, intensity and the use of abortive drugs were recorded at baseline and 3 and 6 months after treatment. Headache frequency was significantly reduced from 4 days/month at baseline to 2 days/month after 3 and 6 months (P < 0.05). The use of abortive drugs decreased from 7 units/month to 4.5 units/month after 3 and 6 months of treatment (P < 0.05). In contrast, headache hours and headache intensity did not change significantly. We could demonstrate a significant reduction of headache frequency following riboflavin treatment. In addition, the number of abortive anti‐migraine tablets was reduced. In line with previous studies our findings show that riboflavin is a safe and well‐tolerated alternative in migraine prophylaxis.Keywords
This publication has 9 references indexed in Scilit:
- B vitamins induce an antinociceptive effect in the acetic acid and formaldehyde models of nociception in miceEuropean Journal of Pharmacology, 2001
- A Comparative Study Of Oral Acetylsalicyclic Acid and Metoprolol for the Prophylactic Treatment of Migraine. A Randomized, Controlled, Double-Blind, Parallel Group Phase III StudyCephalalgia, 2001
- Prophylactic Treatment of Migraine With β‐Blockers and Riboflavin: Differential Effects on the Intensity Dependence of Auditory Evoked Cortical PotentialsHeadache: The Journal of Head and Face Pain, 2000
- Effectiveness of high‐dose riboflavin in migraine prophylaxis A randomized controlled trialNeurology, 1998
- High-Dose Riboflavin as a Prophylactic Treatment of Migraine: Results of an Open Pilot StudyCephalalgia, 1994
- 31 P‐Magnetic resonance spectroscopy in migraine without auraNeurology, 1994
- Abnormal brain and muscle energy metabolism shown by 31 P magnetic resonance spectroscopy in patients affected by migraine with auraNeurology, 1992
- Flunarizine in Prophylaxis of Childhood Migraine: A Double-Blind, Placebo-Controlled, Crossover StudyCephalalgia, 1988
- NADH-CoQ REDUCTASE DEFICIENT MYOPATHY: SUCCESSFUL TREATMENT WITH RIBOFLAVINThe Lancet, 1983